Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000536702 | SCV000653557 | uncertain significance | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-12-31 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 324 of the RTEL1 protein (p.Arg324His). This variant is present in population databases (rs113684274, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with RTEL1-related conditions. This variant is also known as c.1043G>A (p.Arg348His). ClinVar contains an entry for this variant (Variation ID: 473899). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mendelics | RCV000990339 | SCV001141282 | uncertain significance | Dyskeratosis congenita, autosomal recessive 5 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV001007595 | SCV001167274 | likely benign | Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2019-09-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001829595 | SCV002535816 | uncertain significance | Dyskeratosis congenita | 2021-12-08 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002404541 | SCV002705845 | uncertain significance | Inborn genetic diseases | 2024-02-27 | criteria provided, single submitter | clinical testing | The c.1043G>A (p.R348H) alteration is located in exon 12 (coding exon 11) of the RTEL1 gene. This alteration results from a G to A substitution at nucleotide position 1043, causing the arginine (R) at amino acid position 348 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV000990339 | SCV004209815 | uncertain significance | Dyskeratosis congenita, autosomal recessive 5 | 2022-12-06 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003480684 | SCV004225516 | uncertain significance | not provided | 2022-10-03 | criteria provided, single submitter | clinical testing | BP4 |
Gene |
RCV003480684 | SCV005921451 | uncertain significance | not provided | 2024-10-21 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001829595 | SCV002095397 | uncertain significance | Dyskeratosis congenita | 2019-11-11 | no assertion criteria provided | clinical testing |